Editas Medicine shares slip after proposing $125M stock offering
tupungato
Editas Medicine (NASDAQ:EDIT) plans to sell $125 million worth of stock in an underwritten public offering, the company said Wednesday.
The underwriters will have a 30-day option to purchase up to an additional $18.8 million in stock.
The company will be selling all the shares in the offering.
J.P. Morgan Securities, Cowen and Company, and Evercore Group are acting as joint book-running managers for the offering.
Pricing and the number of shares to be offered were not disclosed.
Shares -5.6% at $10.47 after hours.